261 related articles for article (PubMed ID: 9837798)
1. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
[TBL] [Abstract][Full Text] [Related]
2. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
3. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
[TBL] [Abstract][Full Text] [Related]
4. Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
Suter M; Meisinger-Henschel C; Tzatzaris M; Hülsemann V; Lukassen S; Wulff NH; Hausmann J; Howley P; Chaplin P
Vaccine; 2009 Dec; 27(52):7442-50. PubMed ID: 19539582
[TBL] [Abstract][Full Text] [Related]
5. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
Meyer H; Sutter G; Mayr A
J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
[TBL] [Abstract][Full Text] [Related]
6. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
Ramsey-Ewing AL; Moss B
Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
[TBL] [Abstract][Full Text] [Related]
8. SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.
Liu R; Mendez-Rios JD; Peng C; Xiao W; Weisberg AS; Wyatt LS; Moss B
PLoS Pathog; 2019 May; 15(5):e1007710. PubMed ID: 31145755
[TBL] [Abstract][Full Text] [Related]
9. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.
Antoine G; Scheiflinger F; Dorner F; Falkner FG
Virology; 1998 May; 244(2):365-96. PubMed ID: 9601507
[TBL] [Abstract][Full Text] [Related]
10. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs.
Shisler JL; Isaacs SN; Moss B
Virology; 1999 Sep; 262(2):298-311. PubMed ID: 10502509
[TBL] [Abstract][Full Text] [Related]
12. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
Ferrer MF; Zanetti FA; Calamante G
Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
[TBL] [Abstract][Full Text] [Related]
13. The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells.
Hsiao JC; Chung CS; Drillien R; Chang W
Virology; 2004 Nov; 329(1):199-212. PubMed ID: 15476887
[TBL] [Abstract][Full Text] [Related]
14. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
[TBL] [Abstract][Full Text] [Related]
15. The SPI-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation.
Ali AN; Turner PC; Brooks MA; Moyer RW
Virology; 1994 Jul; 202(1):305-14. PubMed ID: 8009842
[TBL] [Abstract][Full Text] [Related]
16. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
[TBL] [Abstract][Full Text] [Related]
17. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
Peng C; Moss B
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
[TBL] [Abstract][Full Text] [Related]
18. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter G; Moss B
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
[TBL] [Abstract][Full Text] [Related]
19. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
[TBL] [Abstract][Full Text] [Related]
20. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]